Deutsche Bank’s Arbutus Biopharma ABUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$351K Sell
113,706
-33,157
-23% -$102K ﹤0.01% 2625
2025
Q1
$513K Sell
146,863
-24,903
-14% -$86.9K ﹤0.01% 2459
2024
Q4
$562K Buy
171,766
+75,212
+78% +$246K ﹤0.01% 2519
2024
Q3
$372K Buy
96,554
+23,759
+33% +$91.5K ﹤0.01% 2578
2024
Q2
$225K Sell
72,795
-63
-0.1% -$195 ﹤0.01% 2705
2024
Q1
$188K Buy
72,858
+6,314
+9% +$16.3K ﹤0.01% 2811
2023
Q4
$166K Sell
66,544
-2,804
-4% -$7.01K ﹤0.01% 2927
2023
Q3
$141K Buy
69,348
+13,838
+25% +$28.1K ﹤0.01% 2972
2023
Q2
$128K Sell
55,510
-16,447
-23% -$37.8K ﹤0.01% 3143
2023
Q1
$218K Buy
71,957
+21,696
+43% +$65.7K ﹤0.01% 2954
2022
Q4
$117K Buy
50,261
+720
+1% +$1.68K ﹤0.01% 3243
2022
Q3
$94K Sell
49,541
-7,217
-13% -$13.7K ﹤0.01% 3317
2022
Q2
$154K Buy
56,758
+13,204
+30% +$35.8K ﹤0.01% 3286
2022
Q1
$130K Sell
43,554
-5,246
-11% -$15.7K ﹤0.01% 3447
2021
Q4
$190K Buy
48,800
+2,584
+6% +$10.1K ﹤0.01% 3375
2021
Q3
$198K Sell
46,216
-329,537
-88% -$1.41M ﹤0.01% 3541
2021
Q2
$1.14M Buy
375,753
+323,186
+615% +$979K ﹤0.01% 2673
2021
Q1
$175K Buy
+52,567
New +$175K ﹤0.01% 3669
2020
Q4
Sell
-127,785
Closed -$400K 4269
2020
Q3
$400K Buy
+127,785
New +$400K ﹤0.01% 2767
2020
Q1
Sell
-1,742
Closed -$4K 4083
2019
Q4
$4K Sell
1,742
-13,070
-88% -$30K ﹤0.01% 4432
2019
Q3
$22K Sell
14,812
-58,195
-80% -$86.4K ﹤0.01% 4109
2019
Q2
$150K Sell
73,007
-58,147
-44% -$119K ﹤0.01% 3888
2019
Q1
$468K Buy
131,154
+20
+0% +$71 ﹤0.01% 3441
2018
Q4
$501K Sell
131,134
-31,471
-19% -$120K ﹤0.01% 3281
2018
Q3
$1.54M Buy
162,605
+57,731
+55% +$545K ﹤0.01% 2994
2018
Q2
$765K Buy
104,874
+39,961
+62% +$291K ﹤0.01% 3565
2018
Q1
$324K Sell
64,913
-98,538
-60% -$492K ﹤0.01% 3859
2017
Q4
$825K Buy
163,451
+32,451
+25% +$164K ﹤0.01% 3270
2017
Q3
$811K Sell
131,000
-50,938
-28% -$315K ﹤0.01% 3106
2017
Q2
$653K Buy
181,938
+47,233
+35% +$170K ﹤0.01% 3225
2017
Q1
$436K Buy
134,705
+45,026
+50% +$146K ﹤0.01% 3075
2016
Q4
$219K Sell
89,679
-111,531
-55% -$272K ﹤0.01% 3487
2016
Q3
$690K Buy
201,210
+14,217
+8% +$48.8K ﹤0.01% 2981
2016
Q2
$650K Buy
186,993
+99,920
+115% +$347K ﹤0.01% 3090
2016
Q1
$358K Sell
87,073
-96,441
-53% -$397K ﹤0.01% 3311
2015
Q4
$816K Buy
183,514
+31,114
+20% +$138K ﹤0.01% 2955
2015
Q3
$927K Buy
152,400
+109,300
+254% +$665K ﹤0.01% 2954
2015
Q2
$510K Buy
43,100
+800
+2% +$9.47K ﹤0.01% 3300
2015
Q1
$738K Sell
42,300
-51,416
-55% -$897K ﹤0.01% 3015
2014
Q4
$1.42M Buy
93,716
+47,616
+103% +$720K ﹤0.01% 2904
2014
Q3
$974K Sell
46,100
-7,146
-13% -$151K ﹤0.01% 2996
2014
Q2
$695K Sell
53,246
-14,054
-21% -$183K ﹤0.01% 3151
2014
Q1
$1.45M Buy
67,300
+15,400
+30% +$331K ﹤0.01% 2613
2013
Q4
$412K Buy
51,900
+5,900
+13% +$46.8K ﹤0.01% 3229
2013
Q3
$319K Buy
+46,000
New +$319K ﹤0.01% 3809